Amgen Inc., the world's largest biotech company, sued units of Roche Holding AG in federal court in Boston, alleging patent infringement of its popular anemia treatment. The lawsuit, filed late Tuesday, claims the Roche units are planning to market one or more anemia treatments that infringe on six patents protecting Epogen, a drug that replicates the kidney hormone erythropoietin, which increases the amount of red blood cells.
November 10, 2005 at 12:00 AM
1 minute read
The original version of this story was published on Law.Com
Amgen Inc., the world’s largest biotech company, sued units of Roche Holding AG in federal court in Boston, alleging patent infringement of its popular anemia treatment.
The lawsuit, filed late Tuesday, claims the Roche units are planning to market one or more anemia treatments that infringe on six patents protecting Epogen, a drug that replicates the kidney hormone erythropoietin, which increases the amount of red blood cells.
Presented by BigVoodoo
Law firms & in-house legal departments with a presence in the middle east celebrate outstanding achievement within the profession.
The premier educational and networking event for employee benefits brokers and agents.
The Legal Intelligencer honors lawyers leaving a mark on the legal community in Pennsylvania and Delaware.
A large and well-established Tampa company is seeking a contracts administrator to support the company's in-house attorney and manage a wide...
We are seeking an attorney to join our commercial finance practice in either our Stamford, Hartford or New Haven offices. Candidates should ...
We are seeking an attorney to join our corporate and transactional practice. Candidates should have a minimum of 8 years of general corporat...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS
